FDA
-
-
-
-
-
-
-
Surrozen Announces an Oversubscribed $175 Million Private Placement of Securities to Focus on Selective Wnt Mimetic Therapeutics to Treat Serious Eye Diseases
334,267 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


